Understand what modern regulators actually expect from IQ, OQ, PQ, and PPQ activities — and how to produce validation evidence that is scientifically defensible, risk-based, and operationally sustainable.
Includes live access & recording
Validation expectations surrounding IQ, OQ, PQ, and PPQ activities continue to evolve as regulated companies balance scientific rigor, operational efficiency, lifecycle management, digitalized systems, and increasing regulatory scrutiny. While most organizations maintain established qualification and validation procedures, many teams still struggle with a critical question: what now constitutes sufficient and defensible validation evidence within modern globally regulated GMP environments?
In practice, validation challenges rarely arise from missing protocols alone. Regulators increasingly evaluate whether validation activities demonstrate meaningful scientific rationale, appropriate risk-based decision-making, traceable execution, and reliable evidence supporting intended system or process performance. Excessive documentation without clear value, inconsistent justification for reduced testing, weak acceptance criteria, poorly supported deviations, and fragmented validation rationale continue to create uncertainty across many organizations.
This practical 90-minute webinar examines modern expectations for IQ, OQ, PQ, and PPQ evidence within today's GMP systems. The session will explore how organizations can distinguish between low-value validation activity and evidence that genuinely demonstrates operational control, process understanding, and defensible qualification practices.
Real-world scenarios and practical examples will be used throughout the session to help participants strengthen validation reasoning, improve evidence quality, support risk-based decision-making, and build more sustainable validation strategies aligned with evolving global GMP expectations.
Many validation teams continue to generate large volumes of qualification and validation documentation, yet uncertainty remains around whether the evidence produced truly supports defensible GMP decision-making. Organizations frequently struggle to determine the appropriate depth of testing, justification for reduced verification activities, management of deviations, and the level of evidence regulators expect to see within modern validation programs.
Regulators increasingly assess not only whether validation activities were completed, but whether the rationale behind testing, acceptance criteria, execution strategies, and final conclusions demonstrates sound scientific and quality judgment.
This webinar provides a practical, experience-driven perspective to help teams evaluate validation sufficiency, avoid low-value documentation practices, improve defensibility, and apply stronger critical thinking when making qualification and process validation decisions.
By the end of this session, participants will be able to evaluate validation evidence quality, strengthen qualification rationale, and build programs that satisfy modern regulatory expectations.
Understand modern global expectations for IQ, OQ, PQ, and PPQ evidence in GMP environments.
Determine what constitutes sufficient and defensible validation documentation under current regulatory scrutiny.
Apply risk-based approaches that appropriately balance scientific rigor, efficiency, and regulatory justification.
Identify common weaknesses in qualification and validation activities before regulators do.
Develop meaningful acceptance criteria and testing rationale that demonstrate sound scientific judgment.
Manage deviations, discrepancies, and validation decision-making in a defensible and traceable manner.
Distinguish low-value documentation from evidence that genuinely demonstrates operational control and process understanding.
Build sustainable validation strategies aligned with evolving global GMP expectations and lifecycle management principles.
Four focused areas that will strengthen how your organization approaches qualification and validation evidence.
Understand what modern regulators evaluate when reviewing IQ, OQ, PQ, and PPQ activities — beyond protocol completeness to scientific rationale and quality judgment.
Learn how to appropriately justify reduced testing, scope validation activities, and document risk-based decisions in a way regulators can evaluate and accept.
Identify the qualification gaps — weak acceptance criteria, poorly supported deviations, fragmented rationale — that most frequently draw regulatory attention.
Build validation programs that are operationally practical and scientifically credible, using real-world scenarios to strengthen evidence quality across your organization.
A comprehensive examination of eight critical dimensions of modern IQ, OQ, PQ, and PPQ validation practice.
Professionals responsible for qualification, validation, and quality systems across pharmaceutical, biotech, and medical device organizations.
Validation and Qualification Teams
Quality Assurance (QA) Departments
Quality Control (QC) Departments
Engineering Departments
Manufacturing Departments
Technical Operations
Regulatory Affairs Departments
Process Development & Technology Transfer
Compliance and Quality Systems Professionals
Validation expectations for IQ, OQ, PQ, and PPQ have shifted significantly over the past decade. Lifecycle-based validation frameworks, risk-based approaches, and Computer Software Assurance (CSA) guidance have changed what regulators expect to see — moving the focus from volume of documentation to quality of scientific rationale and evidence of operational control.
Yet in practice, many organizations continue applying older, more prescriptive validation models. The result is validation programs that generate significant documentation burden while failing to clearly demonstrate the scientific judgment, risk-based decision-making, and traceable execution that modern inspectors increasingly look for. Excessive testing in low-risk areas, weak justification for reduced verification, and fragmented rationale across protocols continue to draw 483 observations.
This session uses real-world scenarios and practical examples to help participants distinguish between documentation that satisfies procedural requirements and evidence that genuinely demonstrates qualification — giving teams a clearer framework for producing validation programs that are both scientifically credible and operationally sustainable within today's globally regulated GMP environments.
Meredith Crabtree has over 30 years' experience in regulated industries, ranging from Blood, Plasma, Tissue, Laboratory, Pharma, Medical Device, Cosmetics, Supplements, and Animal Health. This includes manufacturing, packaging, labelling, and distribution operations.
Meredith is the owner of MLKC Consulting and is a Quality Consultant specializing in product label reviews, 3rd party inspections, Consent Decree and Recall support. She also performs regulatory assessments and Quality trainings.
Don't miss this practical 90-minute session on what now counts as sufficient validation evidence. Strengthen your IQ, OQ, PQ, and PPQ programs and build inspection-ready qualification practices.